Trial · NCT00520130
Adverse events710
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 710
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Metabolism and nutrition disorders | A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm | 28 | 44 | 75 |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Metabolism and nutrition disorders | B - Cyclosporine (AC) Arm | 17 | 45 | 45 |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Metabolism and nutrition disorders | A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm | 26 | 44 | 73 |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Metabolism and nutrition disorders | B - Cyclosporine (AC) Arm | 23 | 45 | 50 |
| other | Acidosis (metabolic or respiratory) | Metabolism and nutrition disorders | A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm | 0 | 44 | 0 |
| other | Acidosis (metabolic or respiratory) | Metabolism and nutrition disorders | B - Cyclosporine (AC) Arm | 1 | 45 | 1 |
| other | Adrenal insufficiency | Endocrine disorders | A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm | 1 | 44 | 1 |
| other | Adrenal insufficiency | Endocrine disorders | B - Cyclosporine (AC) Arm | 1 | 45 | 1 |
| other | Adult Respiratory Distress Syndrome (ARDS) | Respiratory, thoracic and mediastinal disorders | A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm | 1 | 44 | 1 |
| other | Adult Respiratory Distress Syndrome (ARDS) | Respiratory, thoracic and mediastinal disorders | B - Cyclosporine (AC) Arm | 1 | 45 | 1 |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm | 9 | 44 | 15 |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | B - Cyclosporine (AC) Arm | 12 | 45 | 23 |
| other | Alkaline phosphatase | Metabolism and nutrition disorders | A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm | 7 | 44 | 20 |
| other | Alkaline phosphatase | Metabolism and nutrition disorders | B - Cyclosporine (AC) Arm | 6 | 45 | 9 |
| other | Alkalosis (metabolic or respiratory) | Metabolism and nutrition disorders | A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm | 1 | 44 | 1 |
| other | Alkalosis (metabolic or respiratory) | Metabolism and nutrition disorders | B - Cyclosporine (AC) Arm | 0 | 45 | 0 |
| other | Allergic reaction/hypersensitivity (including drug fever) | Immune system disorders | A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm | 1 | 44 | 1 |
| other | Allergic reaction/hypersensitivity (including drug fever) | Immune system disorders | B - Cyclosporine (AC) Arm | 0 | 45 | 0 |
| other | Amylase | Metabolism and nutrition disorders | A - Tacrolimus, Methotrexate, Sirolimus (TMS) Arm | 1 | 44 | 1 |
| other | Amylase | Metabolism and nutrition disorders | B - Cyclosporine (AC) Arm | 1 | 45 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00520130/events